Combination Therapy with KRAS and P38α siRNA Suppresses Colorectal Cancer Growth and Development in SW480 Cell Line.

Shiva KamranEnsiyeh SeyedrezazadehDariush ShanehbandiMilad AsadiVenus ZafariNajibeh ShekariLeila NamvarHabib Zarredar

Published in: Journal of gastrointestinal cancer (2021)

The current study showed that combination therapy with p38α and KRAS siRNA may be considered a novel therapy for colorectal tumor in future.

Keyphrases